With the use of hERG1 inhibitor E4031 daily for 2 weeks starting from the day after inoculum in in vivo experiments, the masses were notably decreased with E4031 treatment, which was paralleled by the decrease in tumor angiogenesis. Here, KCNH2 is linked to neoplasm.